Free Trial

Cellectar Biosciences (CLRB) SEC Filings & 10K Form

Cellectar Biosciences logo
$4.72 -0.12 (-2.48%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$4.76 +0.04 (+0.74%)
As of 08/1/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cellectar Biosciences SEC Filings

DateFilerForm TypeView
07/08/2025
4:02 PM
Cellectar Biosciences (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
07/03/2025
7:02 AM
CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
7:00 AM
Cellectar Biosciences (Issuer)
Kolean Chad J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
7:01 AM
Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
11:15 PM
Cellectar Biosciences (Filer)
Form EFFECT
06/30/2025
7:29 AM
Cellectar Biosciences (Filer)
Form S-1/A
06/26/2025
8:26 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
8:22 AM
Cellectar Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/25/2025
4:22 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
3:45 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
8:26 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
6:02 AM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
6:15 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
5:04 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
3:36 PM
Cellectar Biosciences (Filer)
Form DEFA14A
04/28/2025
3:31 PM
Cellectar Biosciences (Filer)
Form DEF 14A
04/28/2025
3:32 PM
Cellectar Biosciences (Filer)
Form ARS
03/17/2025
3:30 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
6:15 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
5:50 AM
Cellectar Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2025
8:44 PM
Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
2:49 PM
Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
Form SCHEDULE 13G/A
02/06/2025
11:15 PM
Cellectar Biosciences (Filer)
Form EFFECT
02/03/2025
3:57 PM
Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SCHEDULE 13G/A
01/27/2025
9:07 AM
Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
01/14/2025
5:01 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
8:05 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
6:15 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
5:46 AM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
3:53 PM
Cellectar Biosciences (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
11/01/2024
4:15 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
4:03 PM
Cellectar Biosciences (Filer)
Form 10-Q/A
10/29/2024
4:09 PM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
3:56 PM
Cellectar Biosciences (Filer)
Form 10-K/A
08/23/2024
4:15 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
6:15 PM
Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
08/13/2024
5:45 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CLRB) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners